| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.23 | 9e-09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |